{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:46:33Z","timestamp":1788176793910,"version":"build-2803163510"},"reference-count":47,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>The emergency department (ED) is a critical point of contact within the health care system and an opportunity to initiate nonpharmacologic migraine treatment.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine whether progressive muscle relaxation (PMR) smartphone-based migraine self-management improved patient-reported outcomes for migraine compared with enhanced usual care.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>A randomized clinical trial of the smartphone application RELAXaHEAD with and without PMR. Patients aged 18 to 65 years visiting New York University Langone Health EDs for headache who met migraine criteria and self reported 4 or more migraine days per month were recruited from June 2019 to October 2021 with follow-up at 3 months. Data were analyzed from June 2022 to June 2025.<\/jats:p><\/jats:sec>Intervention<\/jats:title>Participants in the intervention group were asked to listen to the app-based PMR for 60 days. Participants in the control group were asked to use the app as a symptom diary.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Primary outcome was change in migraine-related disability (MIDAS). Secondary outcomes were change in migraine-specific quality of life (MSQv2) and monthly headache days (MHDs). Adherence (number of days of diary use, PMR use and total minutes of PMR use over 90-day period) was measured using back-end analytics.<\/jats:p><\/jats:sec>Results<\/jats:title>Of the 94 patients (median [IQR] age, 33 [26-45] years; 57 [82.6%] female) randomized (48 control patients and 46 PMR patients), 69 of 94 (73%) had 1 or more follow-up MIDAS scores and constituted the modified intent-to-treat population (35 control patients and 34 PMR patients). The mean (SD) change in MIDAS scores from baseline to 3 months (last observation carried forward [LOCF] used if missing 3-month follow-up data) differed between groups (PMR, 25.09 [29.64] vs control, 6.86 [59.61]; P<\/jats:italic>\u2009=\u2009.01). PMR had nearly double the number of respondents improving by 5 or more MIDAS points (28 of 34 [82.4%] vs 16 of 35 [45.7%] respondents; P<\/jats:italic>\u2009=\u2009.002). There was no difference in MSQv2 domains from baseline to LOCF between PMR and control (mean [SD] role function preventive domain for PMR, 16.9 [24.5] vs control, 11.3 [25.9]); emotional function domain (mean [SD] for PMR, 26.5 [26.9] vs control, 19.8 [38.5]); and role function restrictive domain (mean [SD] for PMR, 18.1 [22.7] vs control, 18.7 [26.8]). Mean (SD) change in MHDs (baseline to 3 months) did not differ between groups (PMR, 2.9 [8.0]; 23 days vs control, \u22121.6 [6.5]; 25 days).<\/jats:p><\/jats:sec>Conclusion and Relevance<\/jats:title>A PMR-based self-management program offered to patients with migraine after ED discharge yielded clinically significant reductions in migraine-related disability.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT04281030<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.34221","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:00:37Z","timestamp":1760626837000},"page":"e2534221","source":"Crossref","is-referenced-by-count":3,"title":["Smartphone-Based Muscle Relaxation for Migraine in the Emergency Department"],"prefix":"10.1001","volume":"8","author":[{"given":"Mia T.","family":"Minen","sequence":"first","affiliation":[{"name":"Department of Neurology, New York University Langone Health, New York"},{"name":"Department of Population Health, New York University Langone Health, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth K.","family":"Seng","sequence":"additional","affiliation":[{"name":"Ferkauf Graduate School of Psychology, Yeshiva University, New York, New York"},{"name":"Department of Neurology, Albert Einstein College of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin W.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Albert Einstein College of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis D.","family":"George","sequence":"additional","affiliation":[{"name":"Doctoral Program in Psychology, The Graduate Center, City University of New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina M.","family":"Fanning","sequence":"additional","affiliation":[{"name":"MIST Research and Statistical Consulting, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan C.","family":"Bostic","sequence":"additional","affiliation":[{"name":"MIST Research and Statistical Consulting, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W.","family":"Powers","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Cincinnati Children\u2019s Hospital, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Lipton","sequence":"additional","affiliation":[{"name":"Department of Neurology, Albert Einstein College of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"issue":"11","key":"zoi250959r1","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","article-title":"Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"17","author":"GBD 2016 Headache Collaborators","year":"2018","journal-title":"Lancet Neurol"},{"issue":"1","key":"zoi250959r2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s10194-022-01402-2","article-title":"The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates.","volume":"23","author":"Stovner","year":"2022","journal-title":"J Headache Pain"},{"issue":"1","key":"zoi250959r3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000520548","article-title":"Migraine in the emergency department: a prospective multinational study of patient characteristics, management, and outcomes.","volume":"56","author":"Wijeratne","year":"2022","journal-title":"Neuroepidemiology"},{"issue":"2","key":"zoi250959r4","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s40122-021-00331-3","article-title":"Burden of migraine in patients with preventive treatment failure attending European headache specialist centers: real-world evidence from the BECOME study.","volume":"10","author":"Pozo-Rosich","year":"2021","journal-title":"Pain Ther"},{"issue":"1","key":"zoi250959r5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s10194-019-1053-5","article-title":"Headaches in the emergency department -a survey of patients\u2019 characteristics, facts and needs.","volume":"20","author":"Doretti","year":"2019","journal-title":"J Headache Pain"},{"key":"zoi250959r6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.706074","article-title":"Headache characteristics in the neurological emergency department: a retrospective study.","volume":"12","author":"Rimmele","year":"2021","journal-title":"Front Neurol"},{"issue":"10","key":"zoi250959r7","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1111\/head.14239","article-title":"Second-line interventions for migraine in the emergency department: a narrative review.","volume":"61","author":"Kazi","year":"2021","journal-title":"Headache"},{"key":"zoi250959r8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.genhosppsych.2020.12.009","article-title":"Introduction of a smartphone based behavioral intervention for migraine in the emergency department.","volume":"69","author":"Minen","year":"2021","journal-title":"Gen Hosp Psychiatry"},{"issue":"7","key":"zoi250959r10","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/head.13851","article-title":"Understanding what people with migraine consider to be important features of migraine tracking: an analysis of the utilization of smartphone-based migraine tracking with a free-text feature.","volume":"60","author":"Minen","year":"2020","journal-title":"Headache"},{"issue":"2","key":"zoi250959r11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/pm\/pny080","article-title":"User design and experience preferences in a novel smartphone application for migraine management: a think aloud study of the RELAXaHEAD application.","volume":"20","author":"Minen","year":"2019","journal-title":"Pain Med"},{"issue":"46","key":"zoi250959r12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41746-019-0116-y","article-title":"Smartphone-based migraine behavioral therapy: a single-arm study with assessment of mental health predictors.","volume":"2","author":"Minen","year":"2019","journal-title":"NPJ Digit Med"},{"key":"zoi250959r13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.genhosppsych.2020.12.008","article-title":"Heartrate variability biofeedback for migraine using a smartphone application and sensor: a randomized controlled trial.","volume":"69","author":"Minen","year":"2021","journal-title":"Gen Hosp Psychiatry"},{"key":"zoi250959r14","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102489","article-title":"Smartphone based behavioral therapy for pain in multiple sclerosis (MS) patients: a feasibility acceptability randomized controlled study for the treatment of comorbid migraine and ms pain.","volume":"46","author":"Minen","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"zoi250959r15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1089\/neu.2019.6601","article-title":"Feasibility of smartphone-delivered progressive muscle relaxation in persistent post-traumatic headache patients.","volume":"38","author":"Usmani","year":"2021","journal-title":"J Neurotrauma"},{"issue":"10","key":"zoi250959r16","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1111\/head.14010","article-title":"Smartphone-delivered progressive muscle relaxation for the treatment of migraine in primary care: a randomized controlled trial.","volume":"60","author":"Minen","year":"2020","journal-title":"Headache"},{"key":"zoi250959r17","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202","author":"Headache Classification Committee of the International Headache Society","year":"2018","journal-title":"Cephalalgia"},{"issue":"7","key":"zoi250959r18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","article-title":"Prevalence and burden of migraine in the United States: data from the American Migraine Study II.","volume":"41","author":"Lipton","year":"2001","journal-title":"Headache"},{"issue":"6","key":"zoi250959r19","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1212\/WNL.56.suppl_1.S20","article-title":"Development and testing of the Migraine Disability Assessment (MIDAS) questionnaire to assess headache-related disability.","volume":"56","author":"Stewart","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"zoi250959r20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"zoi250959r21","doi-asserted-by":"publisher","DOI":"10.1111\/head.13102","author":"Lipton","year":"2017","journal-title":"Headache"},{"issue":"5","key":"zoi250959r22","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/head.13497","article-title":"Psychometric validation of the role function restrictive domain of the migraine specific quality-of-life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine.","volume":"59","author":"Speck","year":"2019","journal-title":"Headache"},{"key":"zoi250959r23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jclinepi.2015.08.036","article-title":"Clinical validity of PROMIS depression, anxiety, and anger across diverse clinical samples.","volume":"73","author":"Schalet","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"zoi250959r24","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1111\/j.1526-4610.2007.01148.x","article-title":"The headache management trial: a randomized study of coordinated care.","volume":"48","author":"Matchar","year":"2008","journal-title":"Headache"},{"issue":"6","key":"zoi250959r25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.annemergmed.2008.01.334","article-title":"Recurrence of primary headache disorders after emergency department discharge: frequency and predictors of poor pain and functional outcomes.","volume":"52","author":"Friedman","year":"2008","journal-title":"Ann Emerg Med"},{"issue":"10","key":"zoi250959r26","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/j.1553-2712.2012.01458.x","article-title":"A randomized controlled trial of a comprehensive migraine intervention prior to discharge from an emergency department.","volume":"19","author":"Friedman","year":"2012","journal-title":"Acad Emerg Med"},{"issue":"2","key":"zoi250959r27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ajem.2016.11.014","article-title":"Predicting three-month functional outcomes after an ED visit for acute low back pain.","volume":"35","author":"Friedman","year":"2017","journal-title":"Am J Emerg Med"},{"issue":"6","key":"zoi250959r28","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1212\/01.WNL.0000052998.58526.A9","article-title":"Premonitory symptoms in migraine: an electronic diary study.","volume":"60","author":"Giffin","year":"2003","journal-title":"Neurology"},{"issue":"5","key":"zoi250959r29","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1526-4610.2009.01399.x","article-title":"An internet-based migraine headache diary: issues in internet-based research.","volume":"49","author":"Moloney","year":"2009","journal-title":"Headache"},{"issue":"5","key":"zoi250959r30","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jpsychores.2015.09.014","article-title":"Symptom dimensions of affective disorders in migraine patients.","volume":"79","author":"Louter","year":"2015","journal-title":"J Psychosom Res"},{"issue":"1","key":"zoi250959r31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s10194-017-0742-1","article-title":"Anxiety and depression symptoms and migraine: a symptom-based approach research.","volume":"18","author":"Peres","year":"2017","journal-title":"J Headache Pain"},{"issue":"1","key":"zoi250959r32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s10194-022-01396-x","article-title":"Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study).","volume":"23","author":"Barbanti","year":"2022","journal-title":"J Headache Pain"},{"issue":"1","key":"zoi250959r33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s10194-023-01561-w","article-title":"Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study.","volume":"24","author":"Barbanti","year":"2023","journal-title":"J Headache Pain"},{"issue":"1","key":"zoi250959r34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s10194-021-01247-1","article-title":"Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study).","volume":"22","author":"Vernieri","year":"2021","journal-title":"J Headache Pain"},{"issue":"5","key":"zoi250959r35","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1007\/s12325-020-01319-9","article-title":"Efficacy and safety of galcanezumab for the preventive treatment of migraine: a narrative review.","volume":"37","author":"Martin","year":"2020","journal-title":"Adv Ther"},{"issue":"10203","key":"zoi250959r36","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(19)31946-4","article-title":"Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial.","volume":"394","author":"Ferrari","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"zoi250959r37","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1111\/ene.14715","article-title":"Long-term efficacy and safety of erenumab in migraine prevention: results from a 5-year, open-label treatment phase of a randomized clinical trial.","volume":"28","author":"Ashina","year":"2021","journal-title":"Eur J Neurol"},{"issue":"11","key":"zoi250959r38","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1007\/s12325-021-01911-7","article-title":"Galcanezumab in patients with multiple previous migraine preventive medication category failures: results from the open-label period of the CONQUER trial.","volume":"38","author":"Reuter","year":"2021","journal-title":"Adv Ther"},{"issue":"1","key":"zoi250959r39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s10194-019-1024-x","article-title":"Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2).","volume":"20","author":"Silberstein","year":"2019","journal-title":"J Headache Pain"},{"issue":"9","key":"zoi250959r40","doi-asserted-by":"publisher","first-page":"KC01","DOI":"10.7860\/JCDR\/2014\/7546.4854","article-title":"Impact of amitryptiline on migraine disability assessment score.","volume":"8","author":"Moras","year":"2014","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"zoi250959r41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s10194-018-0953-0","article-title":"Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study.","volume":"20","author":"Young","year":"2019","journal-title":"J Headache Pain"},{"issue":"9","key":"zoi250959r42","first-page":"II73","article-title":"Practical implications of item response theory and computerized adaptive testing: a brief summary of ongoing studies of widely used headache impact scales.","volume":"38","author":"Ware","year":"2000","journal-title":"Med Care"},{"issue":"1","key":"zoi250959r43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.annemergmed.2010.02.005","article-title":"Treating headache recurrence after emergency department discharge: a randomized controlled trial of naproxen versus sumatriptan.","volume":"56","author":"Friedman","year":"2010","journal-title":"Ann Emerg Med"},{"issue":"2","key":"zoi250959r44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.annemergmed.2018.09.028","article-title":"A randomized trial of a long-acting depot corticosteroid versus dexamethasone to prevent headache recurrence among patients with acute migraine who are discharged from an emergency department.","volume":"73","author":"Latev","year":"2019","journal-title":"Ann Emerg Med"},{"key":"zoi250959r45","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jad.2019.11.167","article-title":"Dropout rates in clinical trials of smartphone apps for depressive symptoms: a systematic review and meta-analysis.","volume":"263","author":"Torous","year":"2020","journal-title":"J Affect Disord"},{"key":"zoi250959r46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.genhosppsych.2021.05.008","article-title":"Mobile mental health: bridging psychiatry and neurology through engaging innovations.","volume":"75","author":"Torous","year":"2022","journal-title":"Gen Hosp Psychiatry"},{"issue":"7","key":"zoi250959r47","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1176\/appi.ps.201800519","article-title":"User engagement in mental health apps: a review of measurement, reporting, and validity.","volume":"70","author":"Ng","year":"2019","journal-title":"Psychiatr Serv"},{"key":"zoi250959r9","unstructured":"Campbell? KJ, Penzien? DB, Wall? EM. Evidenced-based guidelines for migraine headache: behavioral and physical treatments. American Academy of Neurology. 2000. Accessed August 21, 2025. https:\/\/www.researchgate.net\/profile\/Donald-Penzien\/publication\/254479333_Evidenced-Based_Guidelines_For_Migraine_Headache_Behavioral_and_Physical_Treatments\/links\/546c3cbd0cf20dedafd540f5\/Evidenced-Based-Guidelines-For-Migraine-Headache-Behavioral-and-Physical-Treatments.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2840280\/minen_2025_oi_250959_1760130438.81011.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:00:40Z","timestamp":1760626840000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2840280"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.34221","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]}}}